SCHEMBL170322

SCHEMBL170322

C=C[CH]OCCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9422568 1.00
SCHEMBL6141308 0.98 TSHR (0.42)
SCHEMBL8592154 0.98 TSHR (0.42)
SCHEMBL6141195 0.92
SCHEMBL5735736 0.81
SCHEMBL311220 0.79
SCHEMBL9942449 0.78
Ammonia Solution, Strong SCHEMBL3349086 0.77
SCHEMBL826318 0.77 TSHR (0.46)
SCHEMBL50150 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6662 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-07-18 US claimed
EP-3383377-B1 COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE PROCTER & GAMBLE (US) 2024-04-17 EP claimed
WO-2023244639-A1 METHODS OF PREDICTING CNS CANCER RESPONSE TO TREATMENT WITH EGFR INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-12-21 WO claimed
CN-117120419-A KLK5 bicyclic heteroaromatic inhibitors 拜奥克里斯特制药公司 2023-11-24 CN claimed
CN-116077665-A Compounds for the treatment of ophthalmic diseases and disorders 奇奥拉制药股份有限公司 2023-05-09 CN claimed
WO-2023067322-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2023-04-27 WO claimed
US-20230110003-A1 PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) Valo Health, LLC 2023-04-13 US claimed
US-11597727-B2 Inhibitors of integrin alpha 2 beta 1 and methods of use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-03-07 US claimed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN claimed
US-20210387986-A1 INHIBITORS OF INTEGRIN ALPHA 2 BETA 1 AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-16 US claimed
EP-0044214-A2 Novel phosphorous esters of cyanohydrins, pesticidal compositions including same, and methods of controlling pests using same UNION CARBIDE CORPORATION (US) 1982-01-20 EP claimed
US-4170479-A SILVER HALIDE EMULSION LAYERS OF DIFFERING PHOTOSENSITIVITY FUJI PHOTO FILM CO., LTD. (JP) 1979-10-09 US claimed
US-4115115-A Crystallization of selenium in polymer matrices via in situ generation of organic crystalline nucleation sites XEROX CORPORATION (US) 1978-09-19 US claimed
US-4097408-A FROM DIHYDOPEROXIDE AND CARBONYL COMPOUND, POLYMERIZATION CATALYSTS PENNWALT CORPORATION (US) 1978-06-27 US claimed
US-4050939-A DISPERSION IN POLYMER MATRIX XEROX CORPORATION (US) 1977-09-27 US claimed
US-4050937-A Imagewise exposing and heating a microimaging film containing an organo diselenide, a tertiary phosphine or phosphite and an organic peroxide XEROX CORPORATION (US) 1977-09-27 US claimed
US-4047947-A Process for preparation of transparencies by selective decomposition of an organoselenium compound in a polymeric matrix XEROX CORPORATION (US) 1977-09-13 US claimed
US-4030993-A SELENIUM XEROX CORPORATION (US) 1977-06-21 US claimed
US-3994791-A FORMING SELENIUM FROM ORGANO-SELENIUM COMPOUNDS XEROX CORPORATION (US) 1976-11-30 US claimed
US-3967964-A Photosensitive film comprising an organopolyselenide and an organomercury compound XEROX CORPORATION (US) 1976-07-06 US claimed